Seizures and chronic kidney disease are both common and often coexist. Treating seizures in patients with renal failure, including those on dialysis, is a challenge that is frequently encountered, ...

The findings position Fabhalta to secure a standard approval in IgA nephropathy — a crowded area of drug research — at a time ...

The Food and Drug Administration approved Ozempic for treating patients with chronic kidney disease on Tuesday, marking the latest authorized use for Novo Nordisk’s popular drug known for diabetes and ...

Aug 7 (Reuters) - The U.S. Food and Drug Administration has approved the use of Novartis' (NOVN.S), opens new tab drug to reduce excess protein in the urine of patients with a type of kidney disease, ...

The drug is the only medicine of its kind proven to help patients with lupus nephritis regain full kidney response, the ...

Share on Pinterest A study has found semaglutide sold under brand names Ozempic and Wegovy may lower kidney disease risk. Iuliia Burmistrova/Getty Images Popular GLP-1 drug semaglutide may help ...

Otsuka Pharmaceutical’s kidney disease drug has hit the primary endpoint of a phase 3 trial by demonstrating in an interim analysis the reduction of patients’ urine protein-to-creatine ratio (UPCR) ...

Learn about the current medication options for managing type 2 diabetes and chronic kidney disease, including SGLT2 ...

Novartis has made kidney disorders an area of focus, and it’s now adding a new drug prospect through a deal to acquire Regulus Therapeutics, a biotech with a drug ready for pivotal testing in a rare ...